The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Natural trans fat, dairy fat, partially hydrogenated oils, and cardiometabolic health: the Ludwigshafen Risk and Cardiovascular Health Study: Table 1
Open accessAbstract
This editorial refers to ‘Trans-fatty acids and mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study’†, by M.E. Kleber et al., on page 1072. Kleber and colleagues have investigated levels of trans-fatty acids (TFAs) in erythrocyte membranes and risk of total mortality, cardiovascular mortality, and sudden cardiac death (SCD) in a convenience cohort of German patients hospitalized for angiography.1 After multivariable adjustment, they found that higher levels of total TFAs, and specifically C16 : 1n-7t, were associated with lower risk of SCD (for C16:1n-7t, ∼37% lower risk in the top tertile, compared with the bottom). No other significant associations were identified, including for total TFAs or C16:1n-7t and total or cardiovascular mortality, or for C18:1t or C18:2t and total mortality, cardiovascular mortality, or SCD. How should these findings be interpreted, and what are their implications? In any research study—whether in vitro science, animal experiment, metabolic study, clinical trial, or observational epidemiology—the devil is in the details. Such crucial details are frequently overlooked in our modern age of compressed news, internet, and social media reporting. In this case, the first important detail is the population studied. TFA levels were not measured in a general community, but in patients with chest pain or a positive non-invasive cardiac stress test who were hospitalized for coronary angiography between 1997 and 2000 at a tertiary care centre. Accordingly, these were not generally healthy individuals: for instance, at baseline, 73% had high blood pressure, 50% were taking lipid-lowering medication, and 40% had diabetes. Such patients would often be conscious of their symptoms and health prior to hospitalization, and consequently have altered their dietary behaviours and other lifestyle factors in response to their concern. Such a population produces a classic set-up for ‘reverse causation’: underlying poor health leading to changed behaviours and avoidance of TFA-containing foods (e.g. processed foods, whole-fat dairy), rather than TFA levels predicting future poor health. Is there evidence for such reverse causation in the present study? Yes: those with the lowest TFA levels, i.e. those eating the fewest processed foods and whole-fat dairy, were generally much sicker: they had a higher body mass index, higher blood pressure, more smoking, and substantially more diabetes and worse glucose–insulin homeostasis. TFAs are also known to increase LDL-cholesterol and decrease HDL-cholesterol.2 Yet, in these patients, lower TFA levels were associated with lower HDL-cholesterol and more lipid-lowering therapy—further suggesting reverse causation. This directly contrasts with more general, community-based cohorts (in which reverse causation from pre-existing disease would be less likely), in which higher erythrocyte or phospholipid TFA levels are associated with higher LDL-cholesterol and lower HDL-cholesterol,3,4 as expected. When substantial reverse causation may be present, fully accounting for its effects can be challenging. Thus, the second important detail is the multivariable adjustment that was—and was not—performed. Given the multiple strong associations of lower TFA levels with poor health markers in this population, the first model—only adjusted for age and gender—is not very informative, almost surely burdened by substantial confounding. The second model (‘Model 2’) included many relevant variables. However, it only roughly accounted for significant observed differences in metabolic dysfunction (diabetes, yes/no; hypertension, yes/no), rather than using more discriminative data on levels of systolic and diastolic blood pressure, haemoglobin A1c, and HOMA (homeostatic model assessment) insulin resistance. Not including these produces residual confounding by these factors. Consistent with this, when the authors further adjusted for haemoglobin A1c, antihypertensive medication use, and alcohol, the inverse association of C16:1n-7t with SCD was further attenuated (P for trend = 0.035; Supplementary table S9). It seems plausible that, with further adjustment for blood pressure levels and HOMA insulin resistance, this borderline association would no longer have been statistically significant. The authors also adjusted for levels of blood cholesterol—a major pathway whereby TFAs would influence cardiovascular risk.2 Such adjustment for potential ‘mediating’ variables would attenuate true associations toward the null, making it harder to detect potential harmful effects. Finally, none of the models adjusted for other dietary habits, which were not assessed in these patients. Differences in other diet behaviours across the tertiles of TFAs could appreciably alter the findings, in unpredictable directions. Based on these challenges, i.e. the multiple (12) different TFA–endpoint pairs evaluated, the evidence suggesting reverse causation, the
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These limitations suggest caution in interpreting the results of RCTs or even meta-analyses of RCTs in relation to the effect of a single dietary change on ASCVD [130].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The lack of concordance between studies is due both to methodological problems (particularly inadequate sample sizes or short study durations) and the difficulties of evaluating the impact of a single dietary factor independently of any other changes in the diet [130].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While small amounts of “natural” TFA are found in meats and milk of ruminants (e.g., cow, sheep, goat; formed by gut microorganisms), these contribute minimally to diet (<0.5%E) and do not associate with CVD risk;375 indeed, trans-16:1n-7, a trace TFA biomarker of dairy fat, is linked to lower risk of diabetes and sudden death.247”
From Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review (2016) · cites this paper as [247]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chowdhury, R., Warnakula, S., Kunutsor, S., Crowe, F., Ward, H. A., Johnson, L., Franco, O. H., Butterworth, A. S., Forouhi, N. G., Thompson, S. G., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1788 · Cited by 1,139
Self-citationForouhi, N. G., Koulman, A., Sharp, S. J., Imamura, F., Kröger, J., Schulze, M. B., Crowe, F. L., Huerta, J. M., Guevara, M., Beulens, J. W., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70146-9 · Cited by 557
Aune, D., Norat, T., Romundstad, P., & Vatten, L. J. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.059030 · Cited by 434
Mozaffarian, D., & Clarke, R. (2009) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602976 · Cited by 410 · cited 3×
“The authors also adjusted for levels of blood cholesterol—a major pathway whereby TFAs would influence cardiovascular risk.(2) Such adjustment for potential ‘mediating’ variables would attenuate”
BackgroundInfluentialSelf-citationIntake of fatty acids in Western Europe with emphasis on trans fatty acids: The TRANSFAIR study
Hulshof, K., van Erp-Baart, M., Anttolainen, M., Becker, W., Church, S., Couet, C., Hermann-Kunz, E., Kesteloot, H., Leth, T., Martins, I., et al. (1999) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600692 · Cited by 406
Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis
Chen, M., Sun, Q., Giovannucci, E., Mozaffarian, D., Manson, J. E., Willett, W. C., & Hu, F. B. (2014) · BMC Medicine · doi:10.1186/s12916-014-0215-1 · Cited by 370
Self-citationMozaffarian, D., Cao, H., King, I. B., Lemaitre, R. N., Song, X., Siscovick, D. S., & Hotamisligil, G. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-12-201012210-00005 · Cited by 363
Self-citationMozaffarian, D., de Oliveira Otto, M. C., Lemaitre, R. N., Fretts, A. M., Hotamisligil, G., Tsai, M. Y., Siscovick, D. S., & Nettleton, J. A. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.045468 · Cited by 270
Self-citationA Prospective Study of Trans Fatty Acids in Erythrocytes and Risk of Coronary Heart Disease
Sun, Q., Ma, J., Campos, H., Hankinson, S. E., Manson, J. E., Stampfer, M. J., Rexrode, K. M., Willett, W. C., & Hu, F. B. (2007) · Circulation · doi:10.1161/circulationaha.106.679985 · Cited by 246
Sluijs, I., Forouhi, N. G., Beulens, J. W., van der Schouw, Y. T., Agnoli, C., Arriola, L., Balkau, B., Barricarte, A., Boeing, H., Bueno-de-Mesquita, H. B., et al. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.021907 · Cited by 223
Research works printed but not linked: 1
- US Food and Drug Administration. FDA Cuts Trans Fat in Processed Foods. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm372915.htm .
Cited by
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
“Consistent evidence from epidemiological studies indicates that higher consumption of fruit, non-starchy vegetables, nuts, legumes, fish, vegetable oils, yoghurt, and wholegrains, along with a lower intake of red and processed meats, foods higher in refined carbohydrates, and salt, is associated with a lower incidence…”
Mozaffarian, D. (2016) · Circulation · doi:10.1161/circulationaha.115.018585 · Cited by 2,216
“5%E) and do not associate with CVD risk(375); indeed, trans-16:1n-7, a trace TFA biomarker of dairy fat, is linked to a lower risk of diabetes mellitus and sudden cardiac death.(247) Conversely, high levels of industrially produced TFA can be consumed from partially hydrogenated vegetable oils, which typically contain…”
Self-citation2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab154 · Cited by 542
Mozaffarian, D., & Wu, J. H. Y. (2018) · Circulation Research · doi:10.1161/circresaha.117.309008 · Cited by 303
“As described above, mechanistic explanations for these observations remain unclear, which could include metabolic effects of fermented foods (especially cheese, a major source of dairy fat), links of such biomarkers to MFGM, specific fatty acids (eg, branched-chain fatty acids, MCSFA, and specific ruminant trans fats)…”
BackgroundSelf-citation
Metadata
- Authors
- Mozaffarian, D.
- Affiliations
- Tufts University (US)
- Corresponding author
- Mozaffarian, Dariush
- ORCID
- Mozaffarian, Dariush
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-11-17
- Volume
- 37
- Issue
- 13
- Pages
- 1079-1081
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- PMC
- PMC4816962
- OpenAlex
- W2177500602
- Cited by
- 40
- References
- 18
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 6 · 2018: 5 · 2017: 3 · 2016: 5
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- European Heart Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL085710)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- trans fatty acids, sudden cardiac death, cardiovascular mortality, all-cause mortality, reverse causality, coronary angiography patients, processed foods, dietary behaviour, cardiovascular risk factors, cardiometabolic health, erythrocyte membrane lipids, cardiovascular disease prevention
- MeSH terms
- Dietary Fats, Fatty Acids, Humans, Hydrogen, Hydrogenation, Oils, Risk, Trans Fatty Acids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Natural trans fat, dairy fat, partially hydrogenated oils, and cardiometabolic health: the Ludwigshafen Risk and Cardiovascular Health Study: Table 1. https://app.cochat.ai/papers/10.1093/eurheartj/ehv595
- The paper
- Mozaffarian, D. (2016). Natural trans fat, dairy fat, partially hydrogenated oils, and cardiometabolic health: the Ludwigshafen Risk and Cardiovascular Health Study: Table 1. European Heart Journal. https://doi.org/10.1093/eurheartj/ehv595
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.